Pune, India, April 08, 2019 -- /360iResearch/ -- The report "Global Immuno Oncology Assays Market - Premium Insight, Industry Trends, FPNV Positioning Matrix, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2024 (Q1 2019 Update)", published by 360iResearch, states that the global market was valued at USD 2.47 billion in 2017 and is projected to reach USD 5.43 billion by 2024, growing at a CAGR of 11.95% from 2017 to 2024.
Access Full Report: https://www.360iresearch.com/reports/view/global-immuno-oncology-assays-market
The major forces driving the growth of the immuno oncology assays market include the growing incidences of cancer and adoption of targeted therapy over other treatment options. Moreover, development of bioinformatic tools enhancing the drug development process rise in healthcare expenditure and healthcare insurance and technological advancement and r&d for the treatment of cancer are also some of the factors that are driving the market growth. However certain factors such as the unfavorable regulatory and reimbursement scenario may hinder the market growth. In the middle of difficulty lies opportunity such as the clinical trials to cure different cancers in immunotherapy, and companion diagnostics have the potential to improve immunotherapy efficacy and ensure greater safety. The possible challenges for the market growth is cancer limiting the immune response. But key players in the market are overcoming the challenges with continual improvement and innovation.
Based on indication, the global immuno oncology assays market is studied across Bladder Cancer, Colorectal Cancer, Lung Cancer, and Melanoma. Based on product, the global immuno oncology assays market is studied across Consumables, and Software. Based on technology, the global immuno oncology assays market is studied across Flow Cytometry, Immunoassay, Ngs, and PCR. Based on application, the global immuno oncology assays market is studied across Clinical Diagnostics, and Research. Based on geography, the global immuno oncology assays market is studied across Americas, Europe, Middle East & Africa, and Asia-Pacific.
The report features a competitive scenario of the immuno oncology assays market and provides inclusive analysis of key growth strategies adopted by major players. Key company profiled in the study are Agilent Technologies, Inc., Foundation Medicine, HTG Molecular Diagnostics, Inc., Illumina, Inc., Merck, Nanostring Technologies, Inc., Perkinelmer, Qiagen, Roche Diagnostics, Sartorius AG, and Thermo Fisher Scientific, Inc..
360iResearch LLP, headquartered in Pune, India, is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as Aerospace & Defense, Agriculture, Automotive & Transportation, Building, Construction & Real Estate, Chemicals & Advanced Material, Consumer Goods & Retail, Energy & Utilities, Food & Beverage, Healthcare & Life Sciences, Information Technology, Packaging, and Semiconductor & Electronics.
Miss. Shikha Sachan
India - 412207.
Email: [email protected]